sacituzumab
gilead
['sacituzumab', 'breast', 'sacitu, govi']
the discuss data presented at asco 2023 on sacituzumab govitecan for hr+/her2 metastatic breast cancer #breastcancer #asco2023 
DocWire News delivers the most relevant medical news to over 1M HCPs daily.